Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 190

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

Open access
Kunz, Mauricio, Ceresér, Keila Maria, Goi, Pedro Domingues, Fries, Gabriel Rodrigo, Teixeira, Antonio L., Fernandes, Brisa Simões, Belmonte-de-Abreu, Paulo Silva, Kauer-Sant'Anna, Márcia, Kapczinski, Flavio, Gama, Clarissa Severino · 2011 · Revista Brasileira de Psiquiatria

Abstract

OBJECTIVE: Previous reports suggest that cytokines act as potential mediators of the interaction between the immune and neuroendocrine systems, and that a proinflammatory state may be associated with bipolar disorder and schizophrenia. The aim is to compare cytokine levels in both disorders. METHOD: Twenty euthymic bipolar disorder patients, 53 chronic stabilized schizophrenia patients and 80 healthy controls were recruited. Subjects were all non-smokers and non-obese. Cytokines TNF-α, IL-6, and IL-10 were examined by sandwich ELISA. RESULTS: IL-6 levels were increased in schizophrenia patients when compared to controls (p < 0.0001) and euthymic bipolar disorder patients (p < 0.0001). IL-6 levels were no different in controls compared to euthymic bipolar disorder patients (p = 0.357). IL-10 was lower in controls compared to schizophrenia patients (p = 0.001) or to bipolar disorder patients (p = 0.004). There was no significant difference in TNF-α serum levels among the groups (p = 0.284). Gender-based classification did not significantly alter these findings, and no correlation was found between the antipsychotic dose administered and cytokine levels in patients with schizophrenia. DISCUSSION: These findings evidence a chronic immune activation in schizophrenia. Bipolar disorder seems to present an episode-related inflammatory syndrome. Increased anti-inflammatory factor IL-10 in bipolar disorder and schizophrenia suggests different patterns of inflammatory balance between these two disorders. Results further support the need to investigate cytokines as possible biomarkers of disease activity or treatment response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s1516-44462011000300010

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 30

  1. Berrettini WH, 2000, Are schizophrenic and bipolar disorders related?: A review of family and molecular studies, Biol Psychiatry., 48, 531, 10.1016/S0006-3223(00)00883-0 · DOI · Paper page
  2. Andreazza AC, 2008, Oxidative stress markers in bipolar disorder: a meta-analysis, J Affect Disord., 111, 135, 10.1016/j.jad.2008.04.013 · DOI · Paper page
  3. Gama CS, 2006, Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine, Prog Neuropsychopharmacol Biol Psychiatry., 30, 512, 10.1016/j.pnpbp.2005.11.009 · DOI
  4. Gama CS, 2008, Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males, Neurosci Lett., 433, 270, 10.1016/j.neulet.2008.01.018 · DOI
  5. Vargas HE, 2008, Decreased serum neurotrophin 3 in chronically medicated schizophrenic males, Neurosci Lett., 440, 197, 10.1016/j.neulet.2008.04.027 · DOI
  6. Gama CS, 2007, Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder, Neurosci Lett., 420, 45, 10.1016/j.neulet.2007.04.001 · DOI
  7. Kunz M, 2008, Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry., 32, 1677, 10.1016/j.pnpbp.2008.07.001 · DOI · Paper page
  8. Elkis H, 2008, Brazilian Consensus on second-generation antipsychotics and metabolic disorders, Rev Bras Psiquiatr., 30, 77
  9. Guimaraes LR, 2008, Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet, Prog Neuropsychopharmacol Biol Psychiatry., 32, 1595, 10.1016/j.pnpbp.2008.06.004 · DOI
  10. Leitao-Azevedo CL, 2006, Increased dyslipidemia in schizophrenic outpatients using new generation antipsychotics, Rev Bras Psiquiatr., 28, 301, 10.1590/S1516-44462006005000016 · DOI
  11. Kim YK, 2007, Cytokine imbalance in the pathophysiology of major depressive disorder, Prog Neuropsychopharmacol Biol Psychiatry., 31, 1044, 10.1016/j.pnpbp.2007.03.004 · DOI · Paper page
  12. Yang K, 2007, Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression, Aust N Z J Psychiatry., 41, 266, 10.1080/00048670601057759 · DOI
  13. Goldstein BI, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, J Clin Psychiatry., 70, 1078, 10.4088/JCP.08r04505 · DOI · Paper page
  14. Brietzke E, 2009, Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder, Brain Behav Immun., 23, 1079, 10.1016/j.bbi.2009.04.008 · DOI
  15. Potvin S, 2008, Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review, Biol Psychiatry., 63, 801, 10.1016/j.biopsych.2007.09.024 · DOI · Paper page
  16. Kapczinski F, 2009, The potential use of biomarkers as an adjunctive tool for staging bipolar disorder, Prog Neuropsychopharmacol Biol Psychiatry., 33, 1366, 10.1016/j.pnpbp.2009.07.027 · DOI · Paper page
  17. Rothermundt M, 2001, Review of immunological and immunopathological findings in schizophrenia, Brain Behav Immun., 15, 319, 10.1006/brbi.2001.0648 · DOI · Paper page
  18. Strous RD, 2006, Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited, J Autoimmun., 27, 71, 10.1016/j.jaut.2006.07.006 · DOI · Paper page
  19. Romano F, 1996, Tradução e adaptação de um instrumento de avaliação psicopatológica das psicoses: a escala breve de avaliação psiquiátrica. Versão Ancorada (BPRS-A), J Bras Psiquiatr., 45, 43
  20. Lima MS, 2007, The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study, Rev Bras Psiquiatr., 29, 246, 10.1590/S1516-44462007000300010 · DOI
  21. Hamilton M, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry., 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  22. Naudin J, 1996, Elevated circulating levels of IL-6 in schizophrenia, Schizophr Res., 20, 269, 10.1016/0920-9964(96)00014-X · DOI
  23. Ganguli R, 1994, Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness, Psychiatry Res., 51, 1, 10.1016/0165-1781(94)90042-6 · DOI · Paper page
  24. Erbagci AB, 2001, Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment, Mediators Inflamm., 10, 109, 10.1080/09629350123895 · DOI
  25. Kauer-Sant'Anna M, 2009, Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs: late-stage bipolar disorder, Int J Neuropsychopharmacol., 12, 447, 10.1017/S1461145708009310 · DOI · Paper page
  26. Gama CS, 2008, Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation, Rev Bras Psiquiatr., 30, 337, 10.1590/S1516-44462008000400006 · DOI
  27. Kapczinski F, 2008, Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes, Rev Bras Psiquiatr., 30, 243, 10.1590/S1516-44462008000300011 · DOI
  28. Jacka FN, 2008, Brain-derived neurotrophic factor: a modifiable common mediator in both the pathophysiology of psychiatric illness and in successful pharmacological treatments, Acta Neuropsychiatrica., 20, 223, 10.1111/j.1601-5215.2008.00323.x · DOI
  29. Molteni R, 2002, A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning, Neuroscience., 112, 803, 10.1016/S0306-4522(02)00123-9 · DOI · Paper page
  30. Drzyzga L, 2006, Cytokines in schizophrenia and the effects of antipsychotic drugs, Brain Behav Immun., 20, 532, 10.1016/j.bbi.2006.02.002 · DOI · Paper page

Cited by

See all 190

Metadata

Authors
Kunz, M., Ceresér, K. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer-Sant'Anna, M., Kapczinski, F., & Gama, C. S.
Venue
Revista Brasileira de Psiquiatria
Published
2011-03-18
Volume
33
Issue
3
Pages
268-274
ISSN
  • 1516-4446 (ISSN-L)
  • 1809-452X
OpenAlex
W2159732985
Cited by
190
References
9
FWCI
5.12
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. https://app.cochat.ai/papers/10.1590/s1516-44462011000300010
The paper
Kunz, M., Ceresér, K. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer-Sant'Anna, M., Kapczinski, F., & Gama, C. S. (2011). Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Revista Brasileira de Psiquiatria. https://doi.org/10.1590/s1516-44462011000300010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.